|
|
 |
|
Viewing report
|
|
|
|
Western European Markets for Peripheral Vascular Stents and AAA Stent-Grafts
Frost & Sullivan, Dec 2010, Pages: 80
The objective of this research service is to provide detailed analysis of the largely stable European peripheral vascular stents and AAA stent graft market. This service provides an in-depth analysis of the market split into three segments –Aortic and Carotid Interventions, Abdominal Stents and Lower limb stents. The research service discusses revenues, market share analysis and the competitive landscape on a broader view. It also provides strategies for companies involved in the Peripheral vascular stents and stent graft market. Additionally, the research service provides decision support databases related to hospital resources and healthcare expenditure
Research Overview
This Frost & Sullivan research service titled Western European Markets for Peripheral Vascular Stents and AAA Stent-Grafts offers a comprehensive overview of the market including key drivers, restraints and challenges. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: aortic and carotid interventions, abdominal stents and lower limb stents.
Market Overview
Innovative Drug-device Combinations Promote Market Advancement
The growing popularity among surgeons for drug-device combination products, coupled with advanced imaging techniques that improve the accuracy of surgical procedures using peripheral vascular stents and AAA stent-grafts, are promoting the adoption of such devices. “The treatment of peripheral arterial disease using drug-device combination products is a new practice,” notes the analyst of this research. “The introduction of peripheral vascular drug eluting stents for the treatment of peripheral arterial disease (PAD) has opened up the market for other participants with novel combinations.”
Developments in imaging technology have improved the accuracy and safety of vascular surgery and implantation, leading to an increase in the number of attempted stenting procedures. Refinement of imaging technology has enabled real-time monitoring of both vascular anatomy and function before and during surgery. Technologies that play a significant role in vascular surgery include computed tomography (CT), ultrasound and angiography.
“The positive outcome of clinical trials is encouraging increased stent use,” states the analyst. “While most industry experts concur that the off-label use of peripheral stents is a widespread practice, especially in the United States, it is important to note that indication specific stents are sought by clinicians and offer growth opportunities for manufacturers.” Currently, several clinical trials are underway to prove the safety, efficacy and merits of both renal and carotid stents. Clinical trials for stents serve dual purposes. They attract attention from clinicians, who will ultimately perform such procedures. Furthermore, if the outcomes of these trials are positive, then physicians, specialists and patients alike will be interested in pursuing stent procedures as a treatment for renal and carotid vascular diseases, thereby increasing the market for stents.
“Offering one-stop-shop solutions, developing long-standing client relationships, fostering extensive distribution channels and investing in R&D will be key competitive factors,” advises the analyst. “Developing local market knowledge, forging flexible collaborative alliances with end users and designing niche products will also be key to success.”
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market segments in this research:
- Aortic and carotid interventions
- Abdominal stents
- Lower limb stents
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
